Clinical Trials
36 trialsTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
National Institutes of Health Clinical Center (CC)
A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
Pfizer
Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer
Ohio State University Comprehensive Cancer Center
ASAP
Avera McKennan Hospital & University Health Center
Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
M.D. Anderson Cancer Center
DETERMINE
Cancer Research UK
The Florida ASCENT Study
University of Florida
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
M.D. Anderson Cancer Center
PEPOH
University of Salamanca
DETERMINE
Cancer Research UK
DETERMINE
Cancer Research UK
An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies
Incyte Corporation
Remote Monitoring in Cancer Care: A Platform Study
Mayo Clinic
EARN
Washington University School of Medicine
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Dana-Farber Cancer Institute
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
MOM
Inova Health Care Services
TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies
Shenzhen TargetRx Co., Ltd.
Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels
Ipsen
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
National Cancer Institute (NCI)
A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors
Pfizer
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms
MacroGenics
GBCPRT0008
Global BioClinical
A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers
AbbVie
Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies
Fred Hutchinson Cancer Center
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients
Seoul National University Hospital
SIGNATURE
Pfizer
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Celgene
SIGNATURE
Novartis
An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies
Incyte Corporation
N1
CureOne
Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations
Incyte Corporation
SIGNATURE
Novartis
Screening to Predict Weight Loss in Patients With Cancer
National Cancer Institute (NCI)